Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

721 articles

Research Review

Showing 1–2 of 2 articles · Keyword: Nanotheranostics Clear keyword

Journal of nanobiotechnology2026ReviewDrug Delivery

1. Precision targeting and regenerative therapies in articular cartilage diseases with AI-driven theranostics

Pan Y, Peng Y, Han J, Zhang W, Xu X, Zhao M, Et Al.

Arthrochondral disorders affect the cartilage within joints, leading to symptoms such as discomfort, stiffness, and restricted movement. The barrier characteristics, such as the dense, negatively charged extracellular matrix (ECM) and limited vascular pathways, restrict the penetration, retention, and therapeutic…

Read the article

International journal of nanomedicine2026ReviewNon-viral Gene DeliveryDrug Delivery

2. Artificial Intelligence-Enabled Nanomedicine in Precision Oncology: Diagnosis, Targeted Therapy, and Clinical Translation

Altahla R, Wang Y, Morshedi Yekta M, Wang Z, Jiang H, Li C, Et Al.

Cancer nanomedicine offers programmable platforms for diagnosis, imaging, drug and gene delivery, and theranostics, but its clinical performance is constrained by tumor heterogeneity, complex nano-bio interactions, and interpatient variability. Artificial intelligence (AI) provides a means to integrate…

Read the article

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.